Sudeep Pharma Limited (NSE:SUDEEPPHRM)

India flag India · Delayed Price · Currency is INR
583.25
-1.40 (-0.24%)
At close: Mar 6, 2026
-20.10%
Market Cap 63.00B
Revenue (ttm) 6.17B
Net Income (ttm) 1.68B
Shares Out 112.95M
EPS (ttm) 15.40
PE Ratio 36.23
Forward PE 33.45
Dividend n/a
Ex-Dividend Date n/a
Volume 18,364
Average Volume 83,196
Open 582.30
Previous Close 584.65
Day's Range 581.00 - 596.50
52-Week Range 524.05 - 795.00
Beta n/a
RSI 31.60
Earnings Date Aug 19, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1989
Employees 740
Stock Exchange National Stock Exchange of India
Ticker Symbol SUDEEPPHRM
Full Company Profile

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.

Financial Statements

News

There is no news available yet.